Untitled ItemTrends in clinical trials for stroke by cell therapy: data mining ClinicalTrials.gov and the ICTRP portal site

We examined the clinical research trends related to cell therapy
products in the stroke field based on data obtained from the ClinicalTrials.gov
website and International Clinical Trials Research Platform (ICTRP) portal site. We selected 78
cell therapy studies related to the field of stroke treatment from
ClinicalTrial.gov and ICTRP. These were analyzed according
to e.g., the reporting countries, origin (autologous or allogeneic), of cell
used, cell types and source organs, the progress of translational phases,
target phase of the disease (acute or chronic stroke), and route of
administration. This analysis revealed a trend whereby in the acute phase, mesenchymal
stem cells were
administered intravenously at a relatively higher dose, whereas in the chronic
phase a small number of cells were administered intracranially.